Clinical Trial Update: Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma [Phase 1]

View source ↗

Summary

Phase I/II trial evaluating radiation with bevacizumab (Avastin) and erlotinib (Tarceva) for pancreatic cancer has completed. Results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Tarceva (erlotinib)

Snippet

Sponsor: Duke University | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED | Results posted: 2011-11-24